Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline and Escitalopram in Post-PCI Depression
NCT03841474Unknown
- Sponsor
- Clinical Hospital Center Zagreb
- Start
- Mar 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sertraline and escitalopram in major depressive disorder (MDD), sponsored by Clinical Hospital Center Zagreb. Primary endpoints: Montgomery Asberg Depression Scale at 6 months, Hamilton Rating Scale for Depression at 6 months and 1 more. Status: unknown.
02
Drugs
sertralineescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03841474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03841474.